$AMRI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALBANY MOLECULAR RESEARCH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALBANY MOLECULAR RESEARCH INC. Get notifications about new insider transactions in ALBANY MOLECULAR RESEARCH INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 14 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | S | 18.50 | 20,000 | 370,000 | 2,607,684 | 2.6 M to 2.6 M (-0.76 %) |
Apr 14 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 18.50 | 20,000 | 370,000 | 2,455,818 | 2.5 M to 2.5 M (-0.81 %) |
Apr 08 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | M | 5.99 | 12,367 | 74,078 | 0 | |
Apr 08 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | M | 2.59 | 10,000 | 25,900 | 0 | |
Apr 08 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Buy | M | 5.99 | 12,367 | 74,078 | 437,214 | 424.8 K to 437.2 K (+2.91 %) |
Apr 08 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Buy | M | 2.59 | 10,000 | 25,900 | 424,847 | 414.8 K to 424.8 K (+2.41 %) |
Apr 03 2015 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 17.21 | 30,000 | 516,270 | 3,940,983 | 4 M to 3.9 M (-0.76 %) |
Mar 19 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 18.53 | 3,500 | 64,855 | 27,700 | 31.2 K to 27.7 K (-11.22 %) |
Mar 16 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 18.79 | 441 | 8,286 | 31,200 | 31.6 K to 31.2 K (-1.39 %) |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | M | 11.85 | 5,000 | 59,250 | 0 | |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Sell | S | 18.26 | 5,000 | 91,300 | 39,495 | 44.5 K to 39.5 K (-11.24 %) |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Buy | M | 11.85 | 5,000 | 59,250 | 44,495 | 39.5 K to 44.5 K (+12.66 %) |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | M | 11.85 | 5,000 | 59,250 | 0 | |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Sell | S | 18.22 | 5,000 | 91,100 | 42,849 | 47.8 K to 42.8 K (-10.45 %) |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | M | 11.85 | 5,000 | 59,250 | 47,849 | 42.8 K to 47.8 K (+11.67 %) |
Mar 12 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 18.30 | 721 | 13,194 | 31,641 | 32.4 K to 31.6 K (-2.23 %) |
Mar 11 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 17.65 | 20,000 | 353,000 | 2,475,818 | 2.5 M to 2.5 M (-0.80 %) |
Mar 11 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | S | 17.65 | 20,000 | 353,000 | 2,627,684 | 2.6 M to 2.6 M (-0.76 %) |
Mar 11 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Commercial Of ... | Buy | P | 17.72 | 10,000 | 177,200 | 70,673 | 60.7 K to 70.7 K (+16.48 %) |
Mar 10 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 0.00 | 259 | 0 | 32,362 | 32.6 K to 32.4 K (-0.79 %) |
Mar 06 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Buy | P | 17.70 | 20,000 | 354,000 | 414,847 | 394.8 K to 414.8 K (+5.07 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 13.84 | 940 | 13,010 | 394,847 | 393.9 K to 394.8 K (+0.24 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 17.05 | 58,651 | 1,000,000 | 393,907 | 335.3 K to 393.9 K (+17.49 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 17.05 | 2,639 | 44,995 | 33,513 | 30.9 K to 33.5 K (+8.55 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Grant | A | 17.05 | 2,639 | 44,995 | 39,495 | 36.9 K to 39.5 K (+7.16 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Grant | A | 17.05 | 2,639 | 44,995 | 37,741 | 35.1 K to 37.7 K (+7.52 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | LEUNG GABRIEL | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | LEUNG GABRIEL | Director | Grant | A | 17.05 | 2,639 | 44,995 | 31,316 | 28.7 K to 31.3 K (+9.20 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 17.05 | 2,639 | 44,995 | 42,849 | 40.2 K to 42.8 K (+6.56 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Commercial Of ... | Option Exercise | A | 17.05 | 19,078 | 325,280 | 19,078 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Commercial Of ... | Grant | A | 17.05 | 8,824 | 150,449 | 60,673 | 51.8 K to 60.7 K (+17.02 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP & Treasurer | Option Exercise | A | 17.05 | 19,078 | 325,280 | 19,078 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP & Treasurer | Grant | A | 17.05 | 8,824 | 150,449 | 33,824 | 25 K to 33.8 K (+35.30 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | A | 17.05 | 16,280 | 277,574 | 16,280 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Grant | A | 17.05 | 7,530 | 128,387 | 32,621 | 25.1 K to 32.6 K (+30.01 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Option Exercise | A | 17.05 | 22,893 | 390,326 | 22,893 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Grant | A | 17.05 | 10,588 | 180,525 | 46,134 | 35.5 K to 46.1 K (+29.79 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Grant | A | 17.05 | 2,639 | 44,995 | 2,647,684 | 2.6 M to 2.6 M (+0.10 %) |
Mar 03 2015 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 16.39 | 30,000 | 491,736 | 3,970,983 | 4 M to 4 M (-0.75 %) |
Feb 27 2015 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | CFO | Option Exercise | M | 3.43 | 5,000 | 17,150 | 70,000 | |
Feb 27 2015 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | CFO | Sell | S | 16.17 | 5,000 | 80,850 | 68,318 | 73.3 K to 68.3 K (-6.82 %) |
Feb 27 2015 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | CFO | Buy | M | 3.43 | 5,000 | 17,150 | 73,318 | 68.3 K to 73.3 K (+7.32 %) |
Feb 25 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Option Exercise | M | 5.99 | 3,750 | 22,463 | 15,000 | |
Feb 25 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | S | 16.22 | 3,750 | 60,825 | 25,091 | 28.8 K to 25.1 K (-13.00 %) |
Feb 25 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Buy | M | 5.99 | 3,750 | 22,463 | 28,841 | 25.1 K to 28.8 K (+14.95 %) |
Feb 20 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Option Exercise | M | 2.93 | 5,000 | 14,650 | 7,500 | |
Feb 20 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | S | 16.46 | 1,250 | 20,575 | 25,091 | 26.3 K to 25.1 K (-4.75 %) |
Feb 20 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Buy | M | 2.93 | 1,250 | 3,663 | 26,341 | 25.1 K to 26.3 K (+4.98 %) |
Feb 20 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | S | 16.60 | 3,750 | 62,250 | 25,091 | 28.8 K to 25.1 K (-13.00 %) |
Feb 20 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Buy | M | 2.93 | 3,750 | 10,988 | 28,841 | 25.1 K to 28.8 K (+14.95 %) |
Feb 20 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | S | 16.48 | 1,623 | 26,747 | 25,091 | 26.7 K to 25.1 K (-6.08 %) |
Feb 19 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Sell | D | 0.00 | 1,458 | 0 | 35,546 | 37 K to 35.5 K (-3.94 %) |
Feb 19 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Payment of Exercise | F | 0.00 | 464 | 0 | 37,004 | 37.5 K to 37 K (-1.24 %) |
Feb 19 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | D | 0.00 | 1,250 | 0 | 26,714 | 28 K to 26.7 K (-4.47 %) |
Feb 19 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Payment of Exercise | F | 0.00 | 529 | 0 | 27,964 | 28.5 K to 28 K (-1.86 %) |
Feb 19 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | D | 0.00 | 6,667 | 0 | 2,645,045 | 2.7 M to 2.6 M (-0.25 %) |
Feb 19 2015 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP & Treasurer | Option Exercise | A | 16.70 | 75,000 | 1,252,500 | 75,000 | |
Feb 19 2015 | AMRI | ALBANY MOLECULAR R ... | Ladin Felicia I | SVP & Treasurer | Grant | A | 16.70 | 25,000 | 417,500 | 25,000 | 0 to 25 K |
Feb 12 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 16.91 | 20,000 | 338,200 | 2,495,818 | 2.5 M to 2.5 M (-0.79 %) |
Feb 12 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | S | 16.91 | 20,000 | 338,200 | 2,651,712 | 2.7 M to 2.7 M (-0.75 %) |
Feb 06 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | SVP Sales & GM of A ... | Grant | A | 13.84 | 1,445 | 19,999 | 51,849 | 50.4 K to 51.8 K (+2.87 %) |
Feb 06 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | SVP Sales & GM of A ... | Payment of Exercise | F | 0.00 | 596 | 0 | 50,404 | 51 K to 50.4 K (-1.17 %) |
Feb 06 2015 | AMRI | ALBANY MOLECULAR R ... | Luther Michael A | Senior VP, Discover ... | Grant | A | 13.84 | 1,184 | 16,387 | 32,455 | 31.3 K to 32.5 K (+3.79 %) |
Feb 06 2015 | AMRI | ALBANY MOLECULAR R ... | Luther Michael A | Senior VP, Discover ... | Payment of Exercise | F | 0.00 | 594 | 0 | 31,271 | 31.9 K to 31.3 K (-1.86 %) |
Feb 06 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Payment of Exercise | F | 0.00 | 1,582 | 0 | 37,468 | 39.1 K to 37.5 K (-4.05 %) |
Feb 06 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Payment of Exercise | F | 0.00 | 661 | 0 | 28,493 | 29.2 K to 28.5 K (-2.27 %) |
Feb 06 2015 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | SVP, CFO and Treasu ... | Payment of Exercise | F | 0.00 | 881 | 0 | 68,318 | 69.2 K to 68.3 K (-1.27 %) |
Feb 03 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Sell | D | 0.00 | 1,459 | 0 | 39,050 | 40.5 K to 39.1 K (-3.60 %) |
Feb 03 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Payment of Exercise | F | 0.00 | 554 | 0 | 40,509 | 41.1 K to 40.5 K (-1.35 %) |
Feb 03 2015 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | SVP, CFO and Treasu ... | Sell | D | 0.00 | 1,667 | 0 | 69,199 | 70.9 K to 69.2 K (-2.35 %) |
Feb 03 2015 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | SVP, CFO and Treasu ... | Payment of Exercise | F | 0.00 | 705 | 0 | 70,866 | 71.6 K to 70.9 K (-0.99 %) |
Feb 03 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | D | 0.00 | 1,250 | 0 | 29,154 | 30.4 K to 29.2 K (-4.11 %) |
Feb 03 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Payment of Exercise | F | 0.00 | 529 | 0 | 30,404 | 30.9 K to 30.4 K (-1.71 %) |
Feb 03 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | D | 0.00 | 6,667 | 0 | 2,671,712 | 2.7 M to 2.7 M (-0.25 %) |
Feb 03 2015 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 16.32 | 30,000 | 489,738 | 4,000,983 | 4 M to 4 M (-0.74 %) |
Jan 13 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 16.45 | 20,000 | 329,000 | 2,515,818 | 2.5 M to 2.5 M (-0.79 %) |
Jan 13 2015 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | S | 16.45 | 20,000 | 329,000 | 2,678,379 | 2.7 M to 2.7 M (-0.74 %) |
Jan 08 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | SVP Sales & GM of A ... | Payment of Exercise | F | 14.84 | 3,584 | 53,187 | 51,000 | 54.6 K to 51 K (-6.57 %) |
Jan 08 2015 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 16.00 | 7,694 | 123,105 | 4,023,289 | 4 M to 4 M (-0.19 %) |
Jan 05 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Payment of Exercise | F | 16.10 | 8,443 | 135,932 | 335,256 | 343.7 K to 335.3 K (-2.46 %) |
Jan 05 2015 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 16.21 | 22,306 | 361,649 | 4,030,983 | 4.1 M to 4 M (-0.55 %) |
Dec 11 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | S | 16.24 | 20,000 | 324,800 | 2,698,379 | 2.7 M to 2.7 M (-0.74 %) |
Dec 11 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 16.24 | 20,000 | 324,800 | 2,535,818 | 2.6 M to 2.5 M (-0.78 %) |
Dec 08 2014 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 16.00 | 13,307 | 212,936 | 4,053,289 | 4.1 M to 4.1 M (-0.33 %) |
Dec 05 2014 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 16.00 | 10,391 | 166,262 | 4,066,596 | 4.1 M to 4.1 M (-0.25 %) |
Dec 05 2014 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 16.00 | 6,302 | 100,845 | 4,076,987 | 4.1 M to 4.1 M (-0.15 %) |
Nov 18 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Option Exercise | M | 8.31 | 10,500 | 87,255 | 0 | |
Nov 18 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | S | 16.06 | 10,500 | 168,630 | 30,933 | 41.4 K to 30.9 K (-25.34 %) |
Nov 18 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Buy | M | 8.31 | 10,500 | 87,255 | 41,433 | 30.9 K to 41.4 K (+33.94 %) |
Nov 13 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Gift | G | 0.00 | 3,500 | 0 | 2,718,379 | 2.7 M to 2.7 M (-0.13 %) |
Nov 13 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Gift | G | 0.00 | 3,500 | 0 | 2,555,818 | 2.6 M to 2.6 M (-0.14 %) |
Nov 12 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 17.07 | 20,000 | 341,400 | 2,559,318 | 2.6 M to 2.6 M (-0.78 %) |
Nov 12 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | S | 17.07 | 20,000 | 341,400 | 2,721,879 | 2.7 M to 2.7 M (-0.73 %) |
Nov 12 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Option Exercise | M | 5.99 | 7,500 | 44,925 | 22,500 | |
Nov 12 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | S | 17.03 | 7,500 | 127,725 | 30,933 | 38.4 K to 30.9 K (-19.51 %) |
Nov 12 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Buy | M | 5.99 | 7,500 | 44,925 | 38,433 | 30.9 K to 38.4 K (+24.25 %) |
Nov 10 2014 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Buy | P | 17.01 | 30,000 | 510,300 | 343,699 | 313.7 K to 343.7 K (+9.56 %) |
Oct 30 2014 | AMRI | ALBANY MOLECULAR R ... | Luther Michael A | Senior VP. Discover ... | Payment of Exercise | F | 22.73 | 1,630 | 37,050 | 31,865 | 33.5 K to 31.9 K (-4.87 %) |
Oct 30 2014 | AMRI | ALBANY MOLECULAR R ... | Luther Michael A | Senior VP. Discover ... | Grant | A | 8.64 | 995 | 8,597 | 33,495 | 32.5 K to 33.5 K (+3.06 %) |
Nov 05 2014 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 23.00 | 30,000 | 689,949 | 4,083,289 | 4.1 M to 4.1 M (-0.73 %) |
Oct 14 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | S | 21.62 | 20,000 | 432,400 | 2,741,879 | 2.8 M to 2.7 M (-0.72 %) |
Oct 14 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 21.62 | 20,000 | 432,400 | 2,579,318 | 2.6 M to 2.6 M (-0.77 %) |
Oct 02 2014 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 21.61 | 30,000 | 648,186 | 4,113,289 | 4.1 M to 4.1 M (-0.72 %) |
Oct 01 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Sell | S | 21.48 | 1,000 | 21,480 | 41,063 | 42.1 K to 41.1 K (-2.38 %) |
Sep 18 2014 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | SVP, CFO and Treasu ... | Payment of Exercise | F | 0.00 | 4,522 | 0 | 71,571 | 76.1 K to 71.6 K (-5.94 %) |
Sep 12 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | S | 20.12 | 20,000 | 402,400 | 2,761,879 | 2.8 M to 2.8 M (-0.72 %) |
Sep 12 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 20.12 | 20,000 | 402,400 | 2,599,318 | 2.6 M to 2.6 M (-0.76 %) |
Sep 03 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Sell | S | 19.56 | 2,500 | 48,900 | 42,063 | 44.6 K to 42.1 K (-5.61 %) |
Sep 04 2014 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 19.30 | 30,000 | 579,003 | 4,143,289 | 4.2 M to 4.1 M (-0.72 %) |
Sep 02 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Option Exercise | M | 5.25 | 1,250 | 6,563 | 3,750 | |
Sep 02 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | S | 19.74 | 1,250 | 24,675 | 30,933 | 32.2 K to 30.9 K (-3.88 %) |
Sep 02 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Buy | M | 5.25 | 1,250 | 6,563 | 32,183 | 30.9 K to 32.2 K (+4.04 %) |
Aug 14 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Gift | G | 0.00 | 20,000 | 0 | 2,781,879 | 2.8 M to 2.8 M (-0.71 %) |
Aug 14 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Gift | G | 0.00 | 20,000 | 0 | 2,619,318 | 2.6 M to 2.6 M (-0.76 %) |
Aug 14 2014 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | SVP, CFO and Treasu ... | Option Exercise | M | 3.43 | 10,000 | 34,300 | 75,000 | |
Aug 14 2014 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | SVP, CFO and Treasu ... | Sell | S | 19.76 | 10,000 | 197,600 | 76,093 | 86.1 K to 76.1 K (-11.62 %) |
Aug 14 2014 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | SVP, CFO and Treasu ... | Buy | M | 3.43 | 10,000 | 34,300 | 86,093 | 76.1 K to 86.1 K (+13.14 %) |
Aug 13 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Option Exercise | M | 4.87 | 30,000 | 146,100 | 50,000 | |
Aug 13 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Sell | S | 19.05 | 30,000 | 571,500 | 44,563 | 74.6 K to 44.6 K (-40.23 %) |
Aug 13 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Buy | M | 4.87 | 30,000 | 146,100 | 74,563 | 44.6 K to 74.6 K (+67.32 %) |
Aug 13 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | S | 18.99 | 20,000 | 379,800 | 2,801,879 | 2.8 M to 2.8 M (-0.71 %) |
Aug 13 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 18.99 | 20,000 | 379,800 | 2,639,318 | 2.7 M to 2.6 M (-0.75 %) |
Aug 04 2014 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 18.69 | 30,000 | 560,634 | 4,173,289 | 4.2 M to 4.2 M (-0.71 %) |
Aug 12 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Option Exercise | M | 5.25 | 10,000 | 52,500 | 1,250 | |
Aug 12 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | S | 18.99 | 10,000 | 189,900 | 30,933 | 40.9 K to 30.9 K (-24.43 %) |
Aug 12 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Buy | M | 5.25 | 10,000 | 52,500 | 40,933 | 30.9 K to 40.9 K (+32.33 %) |
Aug 12 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | S | 18.99 | 797 | 15,135 | 30,933 | 31.7 K to 30.9 K (-2.51 %) |
Aug 01 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Sell | S | 18.56 | 2,500 | 46,400 | 44,563 | 47.1 K to 44.6 K (-5.31 %) |
Jul 14 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 20.94 | 20,000 | 418,800 | 2,659,318 | 2.7 M to 2.7 M (-0.75 %) |
Jul 14 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | S | 20.94 | 20,000 | 418,800 | 2,821,879 | 2.8 M to 2.8 M (-0.70 %) |
Jul 02 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Sell | S | 20.62 | 2,500 | 51,550 | 47,063 | 49.6 K to 47.1 K (-5.04 %) |
Jul 02 2014 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 21.00 | 30,000 | 629,970 | 4,203,289 | 4.2 M to 4.2 M (-0.71 %) |
Jun 06 2014 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Grant | A | 17.16 | 1,165 | 19,991 | 35,102 | 33.9 K to 35.1 K (+3.43 %) |
Jun 04 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Option Exercise | M | 2.93 | 2,500 | 7,325 | 16,250 | |
Jun 04 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | S | 16.93 | 2,500 | 42,325 | 31,730 | 34.2 K to 31.7 K (-7.30 %) |
Jun 04 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | M | 2.93 | 2,500 | 7,325 | 34,230 | 36.7 K to 34.2 K (-6.81 %) |
Jun 04 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Payment of Exercise | F | 0.00 | 453 | 0 | 31,730 | 32.2 K to 31.7 K (-1.41 %) |
Jun 04 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | D | 0.00 | 1,250 | 0 | 32,183 | 33.4 K to 32.2 K (-3.74 %) |
Jun 04 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Payment of Exercise | F | 0.00 | 476 | 0 | 49,563 | 50 K to 49.6 K (-0.95 %) |
Jun 04 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Sell | D | 0.00 | 1,458 | 0 | 50,039 | 51.5 K to 50 K (-2.83 %) |
Jun 04 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Sell | S | 16.32 | 2,500 | 40,800 | 51,497 | 54 K to 51.5 K (-4.63 %) |
Jun 04 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Sell | D | 0.00 | 6,667 | 0 | 2,841,879 | 2.8 M to 2.8 M (-0.23 %) |
Jun 04 2014 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 16.40 | 30,000 | 492,000 | 4,233,289 | 4.3 M to 4.2 M (-0.70 %) |
May 20 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Option Exercise | M | 2.93 | 1,250 | 3,663 | 18,750 | |
May 20 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | S | 15.45 | 1,250 | 19,313 | 33,433 | 34.7 K to 33.4 K (-3.60 %) |